Compare Stocks: VANI, COCH, RLMD, and CGC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CGC Canopy Growth	$1.05	$0.96	$0.84 ▼ $2.38	$470.84M	0.81	3.76 million shs	5.40 million shs
COCH Envoy Medical	$0.75 -0.1%	$0.70	$0.36 ▼ $1.89	$57.93M	1.9	133,136 shs	60,790 shs
RLMD Relmada Therapeutics	$4.63 -0.2%	$5.72	$0.60 ▼ $8.00	$494.95M	0.46	1.26 million shs	985,172 shs
VANI Vivani Medical	$1.38 -2.1%	$1.32	$0.92 ▼ $1.92	$127.19M	2.35	174,742 shs	104,719 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CGC Canopy Growth	0.00%	+2.94%	+15.36%	+0.96%	-13.22%
COCH Envoy Medical	-0.05%	-6.25%	+8.24%	+5.78%	-40.94%
RLMD Relmada Therapeutics	-0.22%	-3.54%	-7.40%	-34.23%	+655.92%
VANI Vivani Medical	-2.13%	-1.43%	-0.72%	+15.00%	+13.11%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CGC Canopy Growth	$1.05	$0.96	$0.84 ▼ $2.38	$470.84M	0.81	3.76 million shs	5.40 million shs
COCH Envoy Medical	$0.75 -0.1%	$0.70	$0.36 ▼ $1.89	$57.93M	1.9	133,136 shs	60,790 shs
RLMD Relmada Therapeutics	$4.63 -0.2%	$5.72	$0.60 ▼ $8.00	$494.95M	0.46	1.26 million shs	985,172 shs
VANI Vivani Medical	$1.38 -2.1%	$1.32	$0.92 ▼ $1.92	$127.19M	2.35	174,742 shs	104,719 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CGC Canopy Growth	0.00%	+2.94%	+15.36%	+0.96%	-13.22%
COCH Envoy Medical	-0.05%	-6.25%	+8.24%	+5.78%	-40.94%
RLMD Relmada Therapeutics	-0.22%	-3.54%	-7.40%	-34.23%	+655.92%
VANI Vivani Medical	-2.13%	-1.43%	-0.72%	+15.00%	+13.11%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CGC Canopy Growth	2.20	Hold	N/A	N/A
COCH Envoy Medical	2.00	Hold	$2.00	166.67% Upside
RLMD Relmada Therapeutics	2.75	Moderate Buy	$12.00	159.18% Upside
VANI Vivani Medical	2.25	Hold	$3.75	171.74% Upside

Current Analyst Ratings Breakdown

Latest VANI, COCH, RLMD, and CGC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2026	COCH Envoy Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$2.50 ➝ $2.00
8/12/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/29/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/27/2026	COCH Envoy Medical	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$2.00
7/21/2026	COCH Envoy Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/15/2026	COCH Envoy Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$2.50
7/14/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/7/2026	VANI Vivani Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/29/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/23/2026	VANI Vivani Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/23/2026	VANI Vivani Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$4.00

(Data available from 8/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CGC Canopy Growth	$251.01M	1.88	N/A	N/A	$1.11 per share	0.95
COCH Envoy Medical	$240K	241.22	N/A	N/A	$0.04 per share	18.75
RLMD Relmada Therapeutics	N/A	N/A	N/A	N/A	$1.94 per share	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	$0.21 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CGC Canopy Growth	-$190.29M	-$0.45	N/A	N/A	N/A	-65.33%	-21.91%	-14.34%	11/6/2026 (Estimated)
COCH Envoy Medical	-$23.76M	-$0.76	N/A	N/A	N/A	-11,304.83%	N/A	-144.13%	11/9/2026 (Estimated)
RLMD Relmada Therapeutics	-$57.38M	-$0.90	N/A	N/A	N/A	N/A	-47.52%	-43.97%	N/A
VANI Vivani Medical	-$26.61M	-$0.35	N/A	N/A	N/A	N/A	-191.05%	-70.91%	N/A

Latest VANI, COCH, RLMD, and CGC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	VANI Vivani Medical	-$0.0833	-$0.07	+$0.0133	-$0.07	N/A	N/A
8/10/2026	Q2 2026	COCH Envoy Medical	-$0.08	-$0.07	+$0.01	-$0.07	$0.05 million	$0.05 million
8/7/2026	Q1 2027	CGC Canopy Growth	-$0.04	-$0.02	+$0.02	-$0.02	$58.21 million	$142.62 million
8/6/2026	Q2 2026	RLMD Relmada Therapeutics	-$0.1995	-$0.11	+$0.0895	-$0.11	N/A	N/A
6/15/2026	Q4 2026	CGC Canopy Growth	-$0.06	-$0.17	-$0.11	-$0.05	$53.43 million	$51.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CGC Canopy Growth	N/A	N/A	N/A	N/A	N/A
COCH Envoy Medical	N/A	N/A	N/A	N/A	N/A
RLMD Relmada Therapeutics	N/A	N/A	N/A	N/A	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CGC Canopy Growth	0.31	3.04	2.39
COCH Envoy Medical	N/A	1.73	1.61
RLMD Relmada Therapeutics	N/A	29.52	29.52
VANI Vivani Medical	N/A	3.25	3.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CGC Canopy Growth	3.33%
COCH Envoy Medical	8.59%
RLMD Relmada Therapeutics	45.24%
VANI Vivani Medical	6.78%

Insider Ownership

Company	Insider Ownership
CGC Canopy Growth	0.35%
COCH Envoy Medical	7.10%
RLMD Relmada Therapeutics	14.50%
VANI Vivani Medical	53.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CGC Canopy Growth	1,128	448.42 million	446.85 million	Optionable
COCH Envoy Medical	34	77.19 million	71.71 million	Not Optionable
RLMD Relmada Therapeutics	10	106.67 million	91.20 million	Optionable
VANI Vivani Medical	20	90.20 million	42.13 million	Optionable

VANI, COCH, RLMD, and CGC Headlines

Recent News About These Companies

Analysts Offer Insights on Healthcare Companies: Vivani Medical (VANI) and InspireMD (NSPR)

August 20 at 3:27 PM | theglobeandmail.com

Vivani Medical Inc U5P

August 19 at 1:16 PM | morningstar.comM

Vivani Medical Updates Investors with Regulation FD Presentation

August 17, 2026 | tipranks.com

Vivani Medical (NASDAQ:VANI) Rating Increased to Hold at Wall Street Zen

August 15, 2026 | americanbankingnews.com

Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold"

August 15, 2026 | marketbeat.com

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026 | finance.yahoo.com

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

August 13, 2026 | marketbeat.com

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026 | globenewswire.com

Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial

August 6, 2026 | finance.yahoo.com

ClearOne (CLRO) stock soars over 98% after hours: Here's what you need to know

August 6, 2026 | msn.com

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic ...

August 6, 2026 | finance.yahoo.com

Vivani Completes Enrollment in SLIM-1 Semaglutide Implant Trial

August 6, 2026 | tipranks.com

Vivani Medical (VANI) to Announce Earnings on Wednesday

August 5, 2026 | marketbeat.com

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

July 14, 2026 | globenewswire.com

Next Frontier In Weight Loss? New Implant Looks To Lock In GLP-1 Results

July 14, 2026 | msn.com

The next GLP-1 bet? Implant draws Novo interest

July 13, 2026 | beckershospitalreview.comB

Vivani Medical

July 13, 2026 | fool.com

Weight-loss implant could one day replace Ozempic injections

July 12, 2026 | msn.com

Novo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani Deal

July 9, 2026 | finance.yahoo.com

Vivani Medical signs agreement with Novo Nordisk to evaluate NPM-139

July 9, 2026 | pharmabiz.comP

Ozempic & Wegovy maker to evaluate long-acting GLP-1 implant that could last up to a year

July 9, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI, COCH, RLMD, and CGC Company Descriptions

Canopy Growth NASDAQ:CGC

$1.05 0.00 (0.00%)

As of 08/21/2026 04:00 PM Eastern

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Envoy Medical NASDAQ:COCH

$0.75 0.00 (-0.05%)

As of 08/21/2026 04:00 PM Eastern

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Relmada Therapeutics NASDAQ:RLMD

$4.63 -0.01 (-0.22%)

As of 08/21/2026 04:00 PM Eastern

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.

Vivani Medical NASDAQ:VANI

$1.38 -0.03 (-2.13%)

As of 08/21/2026 04:00 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VANI, COCH, RLMD, and CGC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VANI, COCH, RLMD, and CGC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VANI, COCH, RLMD, and CGC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI, COCH, RLMD, and CGC Company Descriptions

Canopy Growth NASDAQ:CGC

Envoy Medical NASDAQ:COCH

Relmada Therapeutics NASDAQ:RLMD

Vivani Medical NASDAQ:VANI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VANI, COCH, RLMD, and CGC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VANI, COCH, RLMD, and CGC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VANI, COCH, RLMD, and CGC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI, COCH, RLMD, and CGC Company Descriptions

Canopy Growth NASDAQ:CGC

Envoy Medical NASDAQ:COCH

Relmada Therapeutics NASDAQ:RLMD

Vivani Medical NASDAQ:VANI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools